A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of etanercept in Chinese subjects with active rheumatoid arthritis receiving methotrexate

Trial Profile

A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of etanercept in Chinese subjects with active rheumatoid arthritis receiving methotrexate

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Etanercept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Dec 2007 Status changed from recruitinig to completed.
    • 03 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top